Halozyme Therapeutics (HALO) Profit Margin (2010 - 2026)
Halozyme Therapeutics (HALO) profit margin from Jun 30, 2010 to Mar 31, 2026. The current Halozyme Therapeutics (HALO) profit margin is 39.83%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Halozyme Therapeutics (HALO)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 22.69% | -48.12% |
| 2024 | 43.74% | +28.81% |
| 2023 | 33.96% | +10.90% |
| 2022 | 30.62% | -66.29% |
| 2021 | 90.84% | +88.31% |
| 2020 | 48.24% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | -36.86% | -31.87% |
| 2019 | -54.10% | +44.87% |
| 2019 | -37.34% | -1281.51% |
| 2019 | 3.16% | -105.98% |
| 2018 | -52.90% | -51.45% |
| 2018 | -108.96% | +67.56% |
| 2018 | -65.03% | -26.90% |
| 2018 | -88.95% | -547.25% |
| 2017 | 19.89% | +360.91% |
| 2017 | 4.32% | -104.73% |
| 2017 | -91.14% | -18.08% |
| 2017 | -111.26% | +58.42% |
| 2016 | -70.23% | -22.74% |
| 2016 | -90.89% | +12.78% |
| 2016 | -80.59% | +72.82% |
| 2016 | -46.64% | +95.43% |
| 2015 | -23.86% | -73.75% |
| 2015 | -90.89% | +12.78% |
| 2015 | -80.59% | +72.82% |
| 2015 | -46.64% | -48.62% |
| 2014 | -90.76% | -34.61% |
| 2014 | -138.81% | +56.90% |
| 2014 | -88.47% | -60.11% |
| 2014 | -221.80% | +45.60% |
| 2013 | -152.34% | +26.43% |
| 2013 | -120.49% | -24.01% |
| 2013 | -158.55% | -2.77% |
| 2013 | -163.06% | +28.90% |
| 2012 | -126.51% | -66.30% |
| 2012 | -375.42% | +107.79% |
| 2012 | -180.67% | -11.10% |
| 2012 | -203.23% | +476.58% |
| 2011 | -35.25% | -256.40% |
| 2011 | 22.54% | +67.51% |
| 2011 | 13.45% | -110.52% |
| 2011 | -127.85% | -67.29% |
| 2010 | -390.90% | -8.44% |
| 2009 | -426.92% | N/A |
Comparison Halozyme Therapeutics (HALO) profit margin with competitors
Halozyme Therapeutics (HALO) profit margin is 39.83%.